Let's first talk about what a statistical anomaly I found: the confidence interval crossed 0. The authors pointed out that the risk of adverse outcomes was higher at year 1, 2 & 3 for those who elected to take testosterone. Yet, when they compared the absolute risk difference, the confidence intervals always crossed 0 for each year. In other words, the purported risks are not statistically significant! Check out page 1832 for yourself. If you agree, then there's no need to tear this study apart any further.
But in case you don't agree, I'll analyze the study in more depth over the next day. Hint: several issues that I always address w/my patients considering testosterone therapy were not mentioned in the study.
Tweet
This site complies with the HONcode standard for trustworthy health information:
verify here.
No comments:
Post a Comment